Загрузка...
Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer
BACKGROUND: Adjuvant endocrine therapy beyond 5 years reduces recurrence in patients with estrogen receptor–positive breast cancer. We have previously shown that immunohistochemical markers (IHC4) and two gene expression profile tests (recurrence score [RS] and PAM50 risk of recurrence [ROR]) are as...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3787911/ https://ncbi.nlm.nih.gov/pubmed/24029245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt244 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|